Downregulation of Endocannabinoid Signaling in the Hippocampus Following Chronic Unpredictable Stress

Hill, Matthew N, Patel, Sachin, Carrier, Erica J, Rademacher, David J, Ormerod, Brandi K, Hillard, Cecilia J, Gorzalka, Boris B·2005·Neuropsychopharmacology

Cited by (363)

Items 101–200 of 363

  1. The effects of trauma on brain and body: A unifying role for the midbrain periaqueductal gray
    Terpou, Braeden A., Harricharan, Sherain, McKinnon, Margaret C., Frewen, Paul, Jetly, Rakesh, Lanius, Ruth A. · 2019 · Journal of Neuroscience Research
  2. Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition
    Rossi, Silvia, De Chiara, Valentina, Musella, Alessandra, Sacchetti, Lucia, Cantarella, Cristina, Castelli, Maura, Cavasinni, Francesca, Motta, Caterina, Studer, Valeria, Bernardi, Giorgio et al. · 2010 · Molecular Pharmacology
  3. Cannabinoids and emotionality: a neuroanatomical perspective
    Ryan J. McLaughlin, Gabriella Gobbi · 2011 · Neuroscience
  4. Effects of stress on behavioral flexibility in rodents
    Jessica L. Hurtubise, John G. Howland · 2016 · Neuroscience
  5. Fear relief—toward a new conceptual frame work and what endocannabinoids gotta do with it
    Caitlin J.N. Riebe, Fabrício A. Pamplona, Konny Kamprath, CT Wotjak · 2011 · Neuroscience
  6. Differential response to acute and repeated stress in cannabinoid CB1 receptor knockout newborn and adult mice
    Ester Fride, R. Suris, Joseph Weidenfeld, Raphael Mechoulam · 2005 · Behavioural Pharmacology
  7. The Role of the Endocannabinoid System in Alzheimers Disease: Facts and Hypotheses
    Tiziana Bisogno, Vincenzo Di Marzo · 2008 · Current Pharmaceutical Design
  8. The cannabinoid CB 1 receptor and the endocannabinoid anandamide: possible antidepressant targets
    Francis Rodriguez Bambico, Gabriella Gobbi · 2008 · Expert Opinion on Therapeutic Targets
  9. Endocannabinoid Signaling in the Etiology and Treatment of Major Depressive Illness
    Cecilia J. Hillard, Qing-song Liu · 2014 · Current Pharmaceutical Design
  10. Cognitive Dysfunction in Major Depressive Disorder. A Translational Review in Animal Models of the Disease
    Flavie Darcet, Alain Michel Gardier, Raphaël Gaillard, Denis Joseph Paul David, Jean‐Philippe Guilloux · 2016 · Pharmaceuticals
  11. The endocannabinoid system in mental disorders: Evidence from human brain studies
    Inés Ibarra‐Lecue, Fuencisla Pilar-Cuéllar, Carolina Muguruza, Eva Florensa-Zanuy, Álvaro Díaz, Leyre Urigüen, Elena Castro, Ángel Pazos, Luis Felipe Callado · 2018 · Biochemical Pharmacology
  12. Involvement of the endogenous cannabinoid system in the effects of alcohol in the mesolimbic reward circuit: electrophysiological evidence in vivo
    Simona Perra, Giuliano Pillolla, Miriam Melis, Anna Lisa Muntoni, Gian Luigi Gessa, Marco Pistis · 2005 · Psychopharmacology
  13. Local enhancement of cannabinoid CB1 receptor signalling in the dorsal hippocampus elicits an antidepressant-like effect
    Ryan J. McLaughlin, Matthew N. Hill, Anna C. Morrish, Boris B. Gorzalka · 2007 · Behavioural Pharmacology
  14. Endocannabinoids: Effectors of glucocorticoid signaling
    Georgia Balsevich, Gavin N. Petrie, Matthew N. Hill · 2017 · Frontiers in Neuroendocrinology
  15. Differential effects of the antidepressants tranylcypromine and fluoxetine on limbic cannabinoid receptor binding and endocannabinoid contents
    Hill, Matthew N., Ho, Wing-Sze Vanessa, Hillard, Cecilia J., Gorzalka, Boris B. · 2008 · Journal of Neural Transmission
  16. Translational evidence for a role of endocannabinoids in the etiology and treatment of posttraumatic stress disorder
    Alexander Neumeister, Jordan Seidel, Benjamin Ragen, Robert H. Pietrzak · 2014 · Psychoneuroendocrinology
  17. 2-Arachidonoylglycerol Modulation of Anxiety and Stress Adaptation: From Grass Roots to Novel Therapeutics
    Gaurav Bedse, Mathew N. Hill, Sachin Patel · 2020 · Biological Psychiatry
  18. Facilitation of endocannabinoid effects in the ventral hippocampus modulates anxiety-like behaviors depending on previous stress experience
    Alline Cristina Campos, Frederico Rogério Ferreira, Francisco Silveira Guimarães, José Inácio Lemos · 2010 · Neuroscience
  19. Endocannabinoid modulation of fear responses: learning and state-dependent performance effects
    Christian G. Reich, MH Mohammadi, BE Alger · 2008 · Journal of Psychopharmacology
  20. Enhancement of endocannabinoid signaling and the pharmacotherapy of depression
    Regina A. Mangieri, Daniele Piomelli · 2007 · Pharmacological Research
  21. Impact of Chronic Stress Protocols in Learning and Memory in Rodents: Systematic Review and Meta-Analysis
    Pedro Silva Moreira, Pedro Rocha Almeida, Hugo Leite‐Almeida, Nuno Sousa, Patrí­cio Costa · 2016 · PLoS ONE
  22. Anti-depressive mechanism of repetitive transcranial magnetic stimulation in rat: the role of the endocannabinoid system.
    Hua-Ning Wang, Lei Wang, Rui-Guo Zhang, Yun-Chun Chen, Ling Liu, Fang Gao, H. Nie, Wu-Gang Hou, Z. Peng, Qing-Rong Tan · 2014 · Journal of Psychiatric Research
  23. Neuronal populations mediating the effects of endocannabinoids on stress and emotionality
    Martin Häring, Stephan Guggenhuber, Beat Lutz · 2012 · Neuroscience
  24. Impairments in Endocannabinoid Signaling and Depressive Illness
    Matthew N. Hill · 2009 · JAMA
  25. Endocannabinoids and Mental Disorders
    Tiziana Rubino, Erica Zamberletti, Daniela Parolaro · 2015 · Handbook of experimental pharmacology
  26. Upregulation of CB1 receptor binding in the ventromedial prefrontal cortex promotes proactive stress-coping strategies following chronic stress exposure
    McLaughlin, R.J., Hill, M.N., Dang, S.S., Wainwright, S.R., Galea, L.A.M., Hillard, C.J., Gorzalka, B.B. · 2013 · Behavioural Brain Research
  27. Age of stress exposure modulates the immediate and sustained effects of repeated stress on corticolimbic cannabinoid CB1 receptor binding in male rats
    T. T.- Y. Lee, Matthew N. Hill · 2012 · Neuroscience
  28. The effects of FAAH inhibition on the neural basis of anxiety-related processing in healthy male subjects: a randomized clinical trial
    Martin P. Paulus, Murray B. Stein, Alan N. Simmons, Victoria B. Risbrough, Robin J. Halter, Sandra R. Chaplan · 2020 · Neuropsychopharmacology
  29. Animal models of post-traumatic stress disorder and novel treatment targets
    Dario Aspesi, Graziano Pinna · 2019 · Behavioural Pharmacology
  30. Chronic, noninvasive glucocorticoid administration suppresses limbic endocannabinoid signaling in mice
    Nicole P. Bowles, Matthew N. Hill, Sarah M. Bhagat, Ilia N. Karatsoreos, Cecilia J. Hillard, Bruce S. McEwen · 2011 · Neuroscience
  31. Endocannabinoids in Alzheimer's disease and their impact on normative cognitive performance: a case-control and cohort study
    Jeremy L. Koppel, Heather B. Bradshaw, Terry E. Goldberg, Houman Khalili, Philippe Marambaud, Michael J Walker, Miguel de Jesús Mazorra Pazo, Marc L. Gordon, Erica Christen, Peter Davies · 2009 · Lipids in Health and Disease
  32. Early life stress alters the developmental trajectory of corticolimbic endocannabinoid signaling in male rats
    Matthew N. Hill, Lisa R. Eiland, Tiffany T.-Y. Lee, Cecilia J. Hillard, Bruce S. McEwen · 2018 · Neuropharmacology
  33. Antidepressants and Changes in Concentration of Endocannabinoids and N-Acylethanolamines in Rat Brain Structures
    Irena Smaga, Beata Bystrowska, Dawid Gawliński, Bartosz Pomierny, Piotr Stankowicz, Małgorzata Filip · 2014 · Neurotoxicity Research
  34. Endocannabinoids, exercise, pain, and a path to health with aging
    Bruce A. Watkins · 2018 · Molecular Aspects of Medicine
  35. Some subtypes of endocannabinoid/endovanilloid receptors mediate docosahexaenoic acid-induced enhanced spatial memory in rats
    Jian-Ping Pan, Haiqing Zhang, WeiWang, Yan-Fen Guo, Na-Xiao, Xuehong Cao, Lieju Liu · 2011 · Brain Research
  36. High Times for Painful Blues: The Endocannabinoid System in Pain-Depression Comorbidity
    Marie Fitzgibbon, David P. Finn, Michelle Roche · 2015 · The International Journal of Neuropsychopharmacology
  37. Effects of Δ9-tetrahydrocannabinol on reward and anxiety in rats exposed to chronic unpredictable stress
    Stefanos Fokos, George Panagis · 2009 · Journal of Psychopharmacology
  38. Predator threat stress promotes long lasting anxiety-like behaviors and modulates synaptophysin and CB1 receptors expression in brain areas associated with PTSD symptoms
    Alline Cristina Campos, Frederico Rogério Ferreira, Wilson A. Silva, Francisco Silveira Guimarães · 2012 · Neuroscience Letters
  39. Phytocannabinoids and Endocannabinoids
    Zdeněk Fišar · 2009 · Current Drug Abuse Reviews
  40. Short- and long-term plasticity of the endocannabinoid system in neuropsychiatric and neurological disorders
    Tiziana Bisogno, Vincenzo Di Marzo · 2007 · Pharmacological Research
  41. Alterations in behavioral flexibility by cannabinoid CB1 receptor agonists and antagonists
    Matthew N. Hill, Larissa M. Froese, Anna C. Morrish, Jane C. Sun, Stan Floresco · 2006 · Psychopharmacology
  42. Neuroinflammation and neuroprogression in depression: Effects of alternative drug treatments
    Brandon Richardson, Andrew MacPherson, Francis Rodriguez Bambico · 2022 · Brain Behavior & Immunity - Health
  43. Effects of endocannabinoid and endovanilloid systems on aversive memory extinction
    Daniela Laricchiuta, Diego Centonze, Laura Petrosini · 2013 · Behavioural Brain Research
  44. Reductions in circulating endocannabinoid 2-arachidonoylglycerol levels in healthy human subjects exposed to chronic stressors
    Buqing Yi, И. А. Ничипорук, Michel Nicolas, Stefan Schneider, Matthias Feuerecker, Galina Yu. Vassilieva, Detlef Thieme, Gustav Schelling, Alexander Choukèr · 2016 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  45. Targeting the Endocannabinoid System in Alzheimer's Disease
    Jeremy L. Koppel, Peter Davies · 2008 · Journal of Alzheimer s Disease
  46. A possible role for the endocannabinoid system in the neurobiology of depression
    Gino Serra, Walter Fratta · 2007 · Clinical Practice and Epidemiology in Mental Health
  47. Electroconvulsive shock treatment differentially modulates cortical and subcortical endocannabinoid activity
    Matthew N. Hill, Alasdair M. Barr, W.‐S. Vanessa Ho, Erica J. Carrier, Boris B. Gorzalka, Cecilia J. Hillard · 2007 · Journal of Neurochemistry
  48. Impairments of behavior, information flow between thalamus and cortex, and prefrontal cortical synaptic plasticity in an animal model of depression
    Meina Quan, Chenguang Zheng, Nan Zhang, Dadong Han, Yutao Tian, Tao Zhang, Zhuo Ru Yang · 2011 · Brain Research Bulletin
  49. Increased Cerebral Cannabinoid-1 Receptor Availability Is a Stable Feature of Functional Dyspepsia: A [18F]MK-9470 PET Study
    H. G. Ly, J. Ceccarini, N. Weltens, G. Bormans, K. van Laere, J. Tack, L. van Oudenhove · 2015 · Psychotherapy and Psychosomatics
  50. Chronic stress differentially regulates cannabinoid CB1 receptor binding in distinct hippocampal subfields
    Matthew N. Hill, Richard G Hunter, Bruce S. McEwen · 2009 · European Journal of Pharmacology
  51. Chronic restraint stress impairs endocannabinoid mediated suppression of GABAergic signaling in the hippocampus of adult male rats
    Wen Hu, Mingyue Zhang, Boldizsár Czéh, Weiqi Zhang, Gabriele Flügge · 2011 · Brain Research Bulletin
  52. Chronic stress leads to epigenetic dysregulation in the neuropeptide-Y and cannabinoid CB1 receptor genes in the mouse cingulate cortex
    Ermelinda Lomazzo, Florian König, Leila Abassi, Ruth Jelinek, Beat Lutz · 2016 · Neuropharmacology
  53. Cannabinoid hyperemesis syndrome: A disorder of the HPA axis and sympathetic nervous system?
    John R. Richards · 2017 · Medical Hypotheses
  54. THE ENDOCANNABINOID SYSTEM PROVIDES AN AVENUE FOR EVIDENCE-BASED TREATMENT DEVELOPMENT FOR PTSD: The Cutting Edge: Evidence-Based Treatment Developments for PTSD
    Neumeister, Alexander · 2013 · Depression and Anxiety
  55. Role of the Endocannabinoid System in Depression: from Preclinical to Clinical Evidence
    Vincenzo Micale, Katarína Tabiová, Jana Kučerová, Filippo Drago · 2015 · Springer eBooks
  56. Adolescent chronic mild stress alters hippocampal CB1 receptor-mediated excitatory neurotransmission and plasticity
    Christian G. Reich, G.R. Mihalik, Anthony N. Iskander, Joshua C. Seckler, M.S. Weiss · 2013 · Neuroscience
  57. Serum contents of endocannabinoids are correlated with blood pressure in depressed women
    W.‐S. Vanessa Ho, Matthew N. Hill, Gregory E. Miller, Boris B. Gorzalka, Cecilia J. Hillard · 2012 · Lipids in Health and Disease
  58. Endocannabinoid System Alterations in Posttraumatic Stress Disorder: A Review of Developmental and Accumulative Effects of Trauma
    Anahita Bassir Nia, Ricci L. Bender, Ilan Harpaz‐Rotem · 2019 · Chronic Stress
  59. Expression of the endocannabinoid system in fibroblasts and myofascial tissues
    John M. McPartland · 2008 · Journal of Bodywork and Movement Therapies
  60. Association between cerebral cannabinoid 1 receptor availability and body mass index in patients with food intake disorders and healthy subjects: a [18F]MK-9470 PET study
    Jenny Ceccarini, Nathalie Weltens, Huynh Giao Ly, Jan F. Tack, Lukas Van Oudenhove, Koen Van Laere · 2016 · Translational Psychiatry
  61. Cannabinoid Actions on Neural Stem Cells: Implications for Pathophysiology
    R. Rodrigues, D. Lourenço, S. Paulo, J. Mateus, M. A. Ferreira, Francisco M. Mouro, J. B. Moreira, F. Ribeiro, A. Sebastião, S. Xapelli · 2019 · Molecules
  62. Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition
    Alessandro Papa, Silvia Pasquini, Chiara Contri, Sandra Gemma, Giuseppe Campiani, Stefania Butini, Katia Varani, Fabrizio Vincenzi · 2022 · Cells
  63. Long-lasting recovery of psychotic-like symptoms in isolation-reared rats after chronic but not acute treatment with the cannabinoid antagonist AM251
    Erica Zamberletti, Daniela Viganò, Cinzia Guidali, Tiziana Rubino, Daniela Parolaro · 2010 · The International Journal of Neuropsychopharmacology
  64. Changes in the Brain Endocannabinoid System in Rat Models of Depression
    Irena Smaga, Joanna Jastrzębska, Magdalena Zaniewska, Beata Bystrowska, Dawid Gawliński, Agata Faron‐Górecka, Żaneta Broniowska, Joanna Miszkiel, Małgorzata Filip · 2017 · Neurotoxicity Research
  65. The role of the hippocampus in mediating emotional responses to nicotine and cannabinoids: a possible neural substrate for functional interactions
    María‐Paz Viveros, Eva María Marco, Ricardo Llorente, Laura Lamota · 2007 · Behavioural Pharmacology
  66. [Pharmacological exploitation of the endocannabinoid system: new perspectives for the treatment of depression and anxiety disorders?].
    Viviane M. Saito, Carsten Tobias Wotjak, Fabrício A. Moreira · 2010 · PubMed
  67. Social isolation as a promising animal model of PTSD comorbid suicide: neurosteroids and cannabinoids as possible treatment options
    Andrea Locci, Graziano Pinna · 2018 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  68. Molecular Alterations of the Endocannabinoid System in Psychiatric Disorders
    Daniela Navarro, Ani Gasparyan, Francisco Navarrete, Abraham B. Torregrosa, Gabriel Rubio, Marta Marín, Gabriela B. Acosta, María S. García‐Gutiérrez, Jorge Manzanares · 2022 · International Journal of Molecular Sciences
  69. TRP Channels: New Potential Therapeutic Approaches in CNS Neuropathies
    Maria Beatrice Morelli, Consuelo Amantini, Sonia Liberati, Matteo Santoni, Massimo Nabissi · 2013 · CNS & Neurological Disorders - Drug Targets
  70. Unpredictable Chronic Stress Alters Adenosine Metabolism in Zebrafish Brain
    Fernanda Francine Zimmermann, Stefani Altenhofen, Luiza Wilges Kist, Carlos Eduardo Leite, Maurı́cio Reis Bogo, Giana de Paula Cognato, Carla Denise Bonan · 2015 · Molecular Neurobiology
  71. The intricate link between glucocorticoids and endocannabinoids at stress-relevant synapses in the hypothalamus
    Karen M. Crosby, Jaideep Singh Bains · 2011 · Neuroscience
  72. Modulation of the Endocannabinoids N-Arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) on Executive Functions in Humans
    Ana Beatriz Fagundo, Rafael de la Torre, Susana Jiménez‐Múrcia, Zaida Agüera, Antoni Pastor, Felipe F. Casanueva, Roser Granero, Rosa Baños, Cristina Botella, Amparo del Pino‐Gutiérrez et al. · 2013 · PLoS ONE
  73. An endocannabinoid signal associated with desire for alcohol is suppressed in recently abstinent alcoholics
    Regina A. Mangieri, Kwangik Hong, Daniele Piomelli, Rajita Sinha · 2009 · Psychopharmacology
  74. New Perspectives on the Use of Cannabis in the Treatment of Psychiatric Disorders
    María Scherma, Paolo Masia, Matteo Luca Deidda, Walter Fratta, Gianluigi Tanda, Paola Fadda · 2018 · Medicines
  75. Chronic corticosterone treatment increases the endocannabinoid 2-arachidonylglycerol in the rat amygdala
    Hill, Matthew N., Ho, W.-S.Vanessa, Meier, Sarah E., Gorzalka, Boris B., Hillard, Cecilia J. · 2005 · European Journal of Pharmacology
  76. Endocannabinoid Regulation of Neuroendocrine Systems
    Jeffrey G. Tasker, Chun Chen, Marc O. Fisher, Xin Fu, Jennifer R. Rainville, Grant L. Weiss · 2015 · International review of neurobiology
  77. Roles of TRP Channels in Neurological Diseases
    Rui Wang, Sheng Tu, Jianmin Zhang, Anwen Shao · 2020 · Oxidative Medicine and Cellular Longevity
  78. Lipids in health and disease
    Joshua M. Finkelstein, Marie-Thérèse Heemels, Sadaf Shadan, Ursula Keller Weiss · 2014 · Nature
  79. CB1R dysfunction of inhibitory synapses in the ACC drives chronic social isolation stress-induced social impairments in male mice
    Baolin Guo, Kaiwen Xi, Honghui Mao, Keke Ren, Haoxiang Xiao, Nolan D. Hartley, Yangming Zhang, Jun‐Jun Kang, Yingying Liu, Yuqiao Xie et al. · 2023 · Neuron
  80. The Endocannabinoid/Endovanilloid System and Depression
    Irena Smaga, Beata Bystrowska, Dawid Gawliński, Edmund Przegaliński, Małgorzata Filip · 2014 · Current Neuropharmacology
  81. Chronic Stress Impairs α1-Adrenoceptor-Induced Endocannabinoid-Dependent Synaptic Plasticity in the Dorsal Raphe Nucleus
    Samir Haj‐Dahmane, Roh‐Yu Shen · 2014 · Journal of Neuroscience
  82. Relationships between serotonergic and cannabinoid system in depressive‐like behavior: a PET study with [11C]‐ DASB
    Aurelijus Burokas, Elena Martín‐García, Javier Cuesta, Santiago Rojas, José Raúl Herance, Juan Domingo Gispert, Miquel‐Ángel Serra, Rafael J. Maldonado · 2014 · Journal of Neurochemistry
  83. Cannabinoid-1 receptor: a novel target for the treatment of neuropsychiatric disorders
    K Yaragudri Vinod, Basalingappa L. Hungund · 2006 · Expert Opinion on Therapeutic Targets
  84. Cannabinoid modulation of chronic mild stress-induced selective enhancement of trace fear conditioning in adolescent rats
    Christian G. Reich, Anthony N. Iskander, Michael S Weiss · 2013 · Journal of Psychopharmacology
  85. Sex-dependent influence of chronic mild stress (CMS) on voluntary alcohol consumption; study of neurobiological consequences
    Eva María Marco, Javier Antonio Ballesta, Carlos Irala, María-Donina Hernández, Maria Elisa Serrano Navacerrada, Virginia Mela, Meritxell López‐Gallardo, María‐Paz Viveros · 2016 · Pharmacology Biochemistry and Behavior
  86. Role of endocannabinoid system in dopamine signalling within the reward circuits affected by chronic pain
    Jakub Mlost, Agnieszka Wąsik, Katarzyna Starowicz · 2019 · Pharmacological Research
  87. More Aroused, Less Fatigued: Fatty Acid Amide Hydrolase Gene Polymorphisms Influence Acute Response to Amphetamine
    Andrea M. Dlugos, Ajna Hamidovic, Colin A. Hodgkinson, David A Goldman, Abraham A. Palmer, Harriet de Wit · 2009 · Neuropsychopharmacology
  88. The Endocannabinoid System as a Target for the Treatment of Visceral Obesity and Metabolic Syndrome
    Ioannis Kyrou, George Valsamakis, Constantine Tsigos · 2006 · Annals of the New York Academy of Sciences
  89. Diacylglycerol Lipase-Alpha Regulates Hippocampal-Dependent Learning and Memory Processes in Mice
    Lesley D. Schurman, Moriah Carper, Lauren V. Moncayo, Daisuke Ogasawara, Karen Richardson, Laikang Yu, Xiaojie Liu, Justin L. Poklis, Qing-song Liu, Benjamin F. Cravatt et al. · 2019 · Journal of Neuroscience
  90. Small animal PET imaging of the type 1 cannabinoid receptor in a rodent model for anorexia nervosa
    Cindy Casteels, Nathalie Gérard, Kris van Kuyck, Lies Pottel, Bart Nuttin, Guy M Bormans, Koen Van Laere · 2013 · European Journal of Nuclear Medicine and Molecular Imaging
  91. Impaired brain endocannabinoid tone in the activity‐based model of anorexia nervosa
    Roberto Collu, María Scherma, Fabiana Piscitelli, Elisa Giunti, Valentina Satta, M. Paola Castelli, Roberta Verde, Walter Fratta, Tiziana Bisogno, Paola Fadda · 2019 · International Journal of Eating Disorders
  92. The change of spatial cognition ability in depression rat model and the possible association with down-regulated protein expression of TRPC6
    Ye Liu, Chunhua Liu, Xuan Qin, Minghui Zhu, Zhuo Ru Yang · 2015 · Behavioural Brain Research
  93. Chronic Stress Alters Spatial Representation and Bursting Patterns of Place Cells in Behaving Mice
    Mijeong Park, Chong‐Hyun Kim, Seonmi Jo, Eun Joo Kim, Hyewhon Rhim, Changjoon Justin Lee, Jeansok John Kim, Jeiwon Cho · 2015 · Scientific Reports
  94. Role of hypothalamic cannabinoid receptors in post-stroke depression in rats
    Shanshan Wang, Hong Sun, Sainan Liu, Ting Wang, Jin-Qun Guan, Jianjun Jia · 2016 · Brain Research Bulletin
  95. Cross-sensitization and cross-tolerance between exogenous cannabinoid antinociception and endocannabinoid-mediated stress-induced analgesia
    Richard L. Suplita, Sarah A. Eisenstein, Mark H. Neely, Anna M. Moise, Andrea G. Hohmann · 2007 · Neuropharmacology
  96. Endocannabinoid-serotonin systems interaction in health and disease
    Roberto Colangeli, G. Campbell Teskey, Giuseppe Di Giovanni · 2021 · Progress in brain research
  97. Ginseng total saponins and Fuzi total alkaloids exert antidepressant-like effects in ovariectomized mice through BDNF-mTORC1, autophagy and peripheral metabolic pathways
    Yang Jin, Huanhuan Pang, Lihong Zhao, Fangyi Zhao, Ziqian Cheng, Qianqian Liu, Ranji Cui, Wei Yang, Bingjin Li · 2022 · Phytomedicine
  98. Exercise as an adjunctive treatment for cannabis use disorder
    Angelique G. Brellenthin, Kelli F. Koltyn · 2016 · The American Journal of Drug and Alcohol Abuse
  99. Acute treatment with cannabinoid receptor agonist WIN55212.2 improves prepulse inhibition in psychosocially stressed mice
    Magdalena M. Brzózka, André Fischer, Peter Falkai, Ursula Havemann‐Reinecke · 2010 · Behavioural Brain Research
  100. Antidepressant-like effects of pharmacological inhibition of FAAH activity in socially isolated female rats
    Luca Carnevali, Rosario Statello, Federica Vacondio, Francesca Ferlenghi, Gilberto Spadoni, Silvia Rivara, Marco Mor, Andrea Sgoifo · 2020 · European Neuropsychopharmacology